Kytopen Analysis: $53M Raised
What is Kytopen?
Scalable genome engineering for cell therapies
Location
Cambridge, United States
Employees
11-50
Founded
2017
Product Features & Capabilities
- Flowfect Discover platform for high-throughput transfections
- Flowfect TX platform for large-scale payload delivery
- Non-viral gene delivery solutions
- Automated liquid-handling systems
- Continuous flow transfection technology
Use Cases
Conduct high-throughput transfections for drug discovery; Scale gene delivery from small volumes to large manufacturing; Optimize transfection conditions for next-generation cell therapies; Deliver mRNA, DNA, and CRISPR Cas9 RNP to billions of cells; Integrate with standard liquid handling consumables
See something that needs updating? Suggest edits to this profile.